can semaglutide help with menopause weight gain and Loss in Menopause weight loss with wegovy

Skipping doses or not following the recommended injection schedule can impact the effectiveness of the medication

Chronic Management: Treating Obesity as a Chronic Disease Obesity is a risk factor for many other chronic conditions, including type 2 diabetes, kidney disease, heart disease, and non-alcoholic fatty liver disease

While GLP-1 receptor agonists produce significant overall weight loss, there is no definitive evidence that they selectively target abdominal fat to the exclusion of fat in other body regions

Semaglutide users who are eating less or experiencing GI fluid losses are at higher risk of suboptimal electrolyte status

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese Accessed August 3rd 2025

These medications are usually prescribed after diet and exercise alone havent worked well enough